Page 206 - Remedial Andrology

741. Rowland, D.L., et al. Sex Differences in Attributions to Positive and Negative Sexual Scenarios in
Men and Women With and Without Sexual Problems: Reconsidering Stereotypes. Arch Sex Behav,
2019. 48: 855.
https://pubmed.ncbi.nlm.nih.gov/29980902
742. Kaya, C., et al. Is sexual function in female partners of men with premature ejaculation
compromised? J Sex Marital Ther, 2015. 41: 379.
https://pubmed.ncbi.nlm.nih.gov/24779361
743. Jern, P., et al. Do women’s Relationship Satisfaction and Sexual Functioning Vary as a Function of
Their Male Partners’ Premature Ejaculation Symptoms? J Sex Marital Ther, 2020. 46: 630.
https://pubmed.ncbi.nlm.nih.gov/32410522
744. Rowland, D., et al. Practical tips for sexual counseling and psychotherapy in premature ejaculation.
J Sex Med, 2011. 8 Suppl 4: 342.
https://pubmed.ncbi.nlm.nih.gov/21699672
745. Ventus, D., et al. Vibrator-Assisted Start-Stop Exercises Improve Premature Ejaculation Symptoms:
A Randomized Controlled Trial. Arch Sex Behav, 2020. 49: 1559.
https://pubmed.ncbi.nlm.nih.gov/31741252
746. Stephenson, K.R., et al. Statistical Mediators of the Association Between Mindfulness and Sexual
Experiences in Men with Impaired Sexual Function. Arch Sex Behav, 2020. 49: 1545.
https://pubmed.ncbi.nlm.nih.gov/31713094
747. Optale, G., et al. Smartphone-Based Therapeutic Exercises for Men Affected by Premature
Ejaculation: A Pilot Study. Sex Med, 2020. 8: 461.
https://pubmed.ncbi.nlm.nih.gov/32565067
748. Modi, N.B., et al. Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel
agent for the treatment of premature ejaculation. J Clin Pharmacol, 2006. 46: 301.
https://pubmed.ncbi.nlm.nih.gov/16490806
749. McMahon, C.G. Dapoxetine: a new option in the medical management of premature ejaculation.
Ther Adv Urol, 2012. 4: 233.
https://pubmed.ncbi.nlm.nih.gov/23024705
750. McMahon, C.G., et al. Oral agents for the treatment of premature ejaculation: review of efficacy
and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong
premature ejaculation. J Sex Med, 2011. 8: 2707.
https://pubmed.ncbi.nlm.nih.gov/21771283
751. Li, J., et al. Dapoxetine for the treatment of premature ejaculation: a meta-analysis of randomized
controlled trials with trial sequential analysis. Ann Saudi Med, 2018. 38: 366.
https://pubmed.ncbi.nlm.nih.gov/30284992
752. McMahon, C.G., et al. Efficacy and safety of dapoxetine for the treatment of premature ejaculation:
integrated analysis of results from five phase 3 trials. J Sex Med, 2011. 8: 524.
https://pubmed.ncbi.nlm.nih.gov/21059176
753. McMahon, C., et al. - The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in
Premature Ejaculation Therapy: The PASSION Study. Sex Med, 2016. 4: e18.
https://pubmed.ncbi.nlm.nih.gov/26944775
754. Yue, F.G., et al. - Efficacy of Dapoxetine for the Treatment of Premature Ejaculation: A Meta-analysis
of Randomized Clinical Trials on Intravaginal Ejaculatory Latency Time, Patient-reported Outcomes,
and Adverse Events. Urology. 2015. 85: 856.
https://pubmed.ncbi.nlm.nih.gov/25817107
755. Buvat, J., et al. Dapoxetine for the treatment of premature ejaculation: results from a randomized,
double-blind, placebo-controlled phase 3 trial in 22 countries. Eur Urol, 2009. 55: 957.
https://pubmed.ncbi.nlm.nih.gov/19195772
756. Verze, P., et al. - Comparison of Treatment of Emergent Adverse Events in Men With Premature
Ejaculation Treated With Dapoxetine and Alternate Oral Treatments: Results From a Large
Multinational Observational Trial. J Sex Med, 2016. 13: 194.
https://pubmed.ncbi.nlm.nih.gov/26805941
757. Kowey, P.R., et al. Cardiovascular safety profile of dapoxetine during the premarketing evaluation.
Drugs R D, 2011. 11: 1.
https://pubmed.ncbi.nlm.nih.gov/21410293
758. EMA. Priligy - Article 29 referral - Annex III - Summary of Product Characteristics, Labelling and
Package Leaflet. 2012.
https://www.ema.europa.eu/en/documents/referral/priligy-article-29-referral-annex-iii_en.pdf
759. EMA. Priligy - Article 29 referral - Assessment Report for Priligy and Associated Names. 2012.
https://www.ema.europa.eu/en/documents/referral/priligy-article-29-referral-assessment-report_
en.pdf

SEXUAL AND REPRODUCTIVE HEALTH - MARCH 2021 205